<div><p>The number of fully active antibiotic options that treat nosocomial infections due to multidrug-resistant <i>Acinetobacter baumannii</i> (<i>A. baumannii</i>) is extremely limited. <i>Magnolia officinalis</i>, <i>Mahonia bealei</i>, <i>Rabdosia rubescens</i>, <i>Rosa rugosa</i>, <i>Rubus chingii</i>, <i>Scutellaria baicalensis</i>, and <i>Terminalia chebula</i> plant extracts were previously shown to have growth inhibitory activity against a multidrug-resistant clinical strain of <i>A. baumannii</i>. In this study, the compounds responsible for their antimicrobial activity were identified by fractionating each plant extract using high performance liquid chromatography, and determining the antimicrobial activity of each fraction agai...